Literature DB >> 11517413

Predicted amino acid sequences for 100 JCV strains.

C L Cubitt1, X Cui, H T Agostini, V R Nerurkar, I Scheirich, R Yanagihara, C F Ryschkewitsch, G L Stoner.   

Abstract

DNA sequence variation between JCV genotypes is confined largely to noncoding intergenic regions and introns. Nevertheless, evidence suggests that the amino acid sequence variations among the 8 genotypes of JCV can influence the potential for neurovirulence of the virus. In the current study, the amino acid sequences for 100 JCV genomes were translated and grouped into genotype families. Subtype consensus sequences were determined and the type-specific amino acid sequence variants were identified.

Mesh：

Substances：

Year:  2001        PMID： 11517413     DOI： 10.1080/13550280152537201

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


  13 in total

1.  Genotypes of JC virus in East, Central and Southwest Europe.

Authors:  Hansjürgen T Agostini; Alison Deckhut; David V Jobes; Rosina Girones; Günther Schlunck; Marcin G Prost; Carolina Frias; E Pérez-Trallero; Caroline F Ryschkewitsch; Gerald L Stoner
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

Review 2.  JC virus as a marker of human migration to the Americas.

Authors:  G L Stoner; D V Jobes; M Fernandez Cobo; H T Agostini; S C Chima; C F Ryschkewitsch
Journal:  Microbes Infect       Date:  2000-12       Impact factor: 2.700

3.  Typing of urinary JC virus DNA offers a novel means of tracing human migrations.

Authors:  C Sugimoto; T Kitamura; J Guo; M N Al-Ahdal; S N Shchelkunov; B Otova; P Ondrejka; J Y Chollet; S El-Safi; M Ettayebi; G Grésenguet; T Kocagöz; S Chaiyarasamee; K Z Thant; S Thein; K Moe; N Kobayashi; F Taguchi; Y Yogo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Phylogenetic analysis of 22 complete genomes of the human polyomavirus JC virus.

Authors:  D V Jobes; S C Chima; C F Ryschkewitsch; G L Stoner
Journal:  J Gen Virol       Date:  1998-10       Impact factor: 3.891

5.  Capsid protein VP1 deletions in JC virus from two AIDS patients with progressive multifocal leukoencephalopathy.

Authors:  G L Stoner; C F Ryschkewitsch
Journal:  J Neurovirol       Date:  1995-06       Impact factor: 2.643

6.  Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases.

Authors:  K Kuchelmeister; F Gullotta; M Bergmann; G Angeli; T Masini
Journal:  Pathol Res Pract       Date:  1993-03       Impact factor: 3.250

7.  Complete genome of a JC virus genotype type 6 from the brain of an African American with progressive multifocal leukoencephalopathy.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  J Hum Virol       Date:  1998 May-Jun

8.  JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy.

Authors:  V Dubois; H Moret; M E Lafon; V Brodard; J Icart; A Ruffault; O Guist'hau; C Buffet-Janvresse; K Abbed; E Dussaix; D Ingrand
Journal:  J Infect Dis       Date:  2000-11-29       Impact factor: 5.226

9.  Polyomavirus JC genotypes in an urban United States population reflect the history of African origin and genetic admixture in modern African Americans.

Authors:  S C Chima; C F Ryschkewitsch; K J Fan; G L Stoner
Journal:  Hum Biol       Date:  2000-10       Impact factor: 0.553

Review 10.  Pathology of the central nervous system in patients infected with the human immunodeficiency virus (HIV): a report of 252 autopsy cases from Brazil.

Authors:  L Chimelli; S Rosemberg; M D Hahn; M B Lopes; M B Netto
Journal:  Neuropathol Appl Neurobiol       Date:  1992-10       Impact factor: 8.090
View more
  15 in total

Review 1.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

Review 2.  Genotypes, archetypes, and tandem repeats in the molecular epidemiology and pathogenesis of JC virus induced disease.

Authors:  Walter J Atwood
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

3.  The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity.

Authors:  Luisa J Ströh; Melissa S Maginnis; Bärbel S Blaum; Christian D S Nelson; Ursula Neu; Gretchen V Gee; Bethany A O'Hara; Nasim Motamedi; Daniel DiMaio; Walter J Atwood; Thilo Stehle
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

4.  Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.

Authors:  Leonid Gorelik; Carl Reid; Manuela Testa; Margot Brickelmaier; Simona Bossolasco; Annamaria Pazzi; Arabella Bestetti; Paul Carmillo; Ewa Wilson; Michele McAuliffe; Christopher Tonkin; John P Carulli; Alexey Lugovskoy; Adriano Lazzarin; Shamil Sunyaev; Kenneth Simon; Paola Cinque
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 5.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.

Authors:  Frank J O'Neill; John E Greenlee; Kristina Dörries; Susan A Clawson; Helen Carney
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

7.  JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.

Authors:  Colleen L Mayberry; Christian D S Nelson; Melissa S Maginnis
Journal:  Curr Clin Microbiol Rep       Date:  2017-08-01

8.  Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Molly R Perkins; Caroline Ryschkewitsch; Julia C Liebner; Maria Chiara G Monaco; Danielle Himelfarb; Sara Ireland; Annelys Roque; Heather L Edward; Peter N Jensen; Gina Remington; Thomas Abraham; Jaspreet Abraham; Benjamin Greenberg; Charles Kaufman; Chris LaGanke; Nancy L Monson; Xiaoning Xu; Elliot Frohman; Eugene O Major; Daniel C Douek
Journal:  PLoS Pathog       Date:  2012-11-08       Impact factor: 6.823

9.  Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.

Authors:  Melissa S Maginnis; Luisa J Ströh; Gretchen V Gee; Bethany A O'Hara; Aaron Derdowski; Thilo Stehle; Walter J Atwood
Journal:  MBio       Date:  2013-06-11       Impact factor: 7.867

Review 10.  Human polyomavirus reactivation: disease pathogenesis and treatment approaches.

Authors:  Cillian F De Gascun; Michael J Carr
Journal:  Clin Dev Immunol       Date:  2013-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.